[Cycloplatin (LACHEMA) in ovarian carcinoma. Results of a registered study].
A short report is given on the first results of the Carboplatin registration trial in ovarian cancer. CR 3/10 pat. PR 4/10 pat. remission time 10 ms in average. In comparison with cisplatin the efficacy is similar. The side effects are different particularly the bone marrow was more affected in contrast to cisplatin. The nephrotoxic side effects can be neglected.
Krafft
W
W
Arbeitsgemeinschaft Gynäkologische Onkologie, Gesellschaft für Gynäkologie und Geburtshilfe, Erfurt, Bundesrepublik Deutschland.
Müller
U
U
Hoffmann
J
J
Nöschel
H
H
Schloser
J
J
König
E M
EM
Lorenz
R
R
D000328:Adult; D000368:Aged; D016190:Carboplatin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D016190:Carboplatin
Cycloplatin (LACHEMA) beim Ovarialkarzinom. Ergebnisse einer Registrierungsstudie.